The PricewaterhouseCoopers Pharma & Life Sciences experts are pleased to provide you with the second issue of our Asia-Pacific pharmaceutical industry newsletter.
This issue includes a brief overview of the pharma mergers and acquisitions activity in Asia during 2009. There was a notable increase in M&A activity in the latter part of 2009, gradually coming back to pre-financial crisis levels. Although it is still early in 2010, we are already beginning to see increased appetite in the market.
We like to draw your attention to the speech on Compliance given by the Department of Justice in the US and the fact that multiple investigations are focusing on the business practices in pharmaceutical, medical devices and life sciences companies in Asia and the expectations the US regulator has with respect to compliance with the FCPA.
As in our previous newsletter we also highlight pricing & reimbursement, regulatory and tax news from the different territories.
We hope this newsletter is informative and if you like to discuss any topic in more detail, feel free to reach out to your PwC territory contact or the experts mentioned in the article.